lymphoid tumors conjunctiva orbit rare remain localized majority cases possible clinically histologically differentiate lymphoma nhl benign lymphoid hyperplasia series NUMBER patients reported nineteen classified having malignant nhl NUMBER benign hyperplasia NUMBER NUMBER later developed metastases patients systemic NUMBER stage NUMBER stage ii NUMBER stage iv disease patients received local radiation therapy doses NUMBER NUMBER rad weeks lesions eyelid conjunctiva NUMBER NUMBER rad weeks retrobulbar lesions lens shielded patients NUMBER nhl vitreous body method shielding lens lead block mounted low vac lens described dose distribution eye orbit presented dose ocular lens reduced NUMBER tumor dose technique patients treated doses higher NUMBER rad experienced conjunctivitis skin erythema resolved completely effects radiation normal structures ocular adnexa observed NUMBER patients alive signs tumor months median time NUMBER months non hodgkins work NUMBER NUMBER NUMBER NUMBER NUMBER NUMBER follow